Fidelity Investments’s Thorne Healthtech, Inc. Common Stock THRN Stock Holding History

Fidelity Investments’s Portfolio THRN Stock Details THRN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-1,261	Closed	-$12.8K	–	5759
2023 Q3	$12.8K	Buy	1,261 +408	+48%	+$3.11K	﹤0.01%	4009
2023 Q2	$4.01K	Sell	853 -165	-16%	-$758	﹤0.01%	4425
2023 Q1	$4.7K	Buy	1,018 +898	+748%	+$3.95K	﹤0.01%	4407
2022 Q4	$436	Sell	120 -396	-77%	-$1.76K	﹤0.01%	4762
2022 Q3	$2K	Buy	516 +515	+51,500%	+$2.59K	﹤0.01%	4612
2022 Q2	$0	Sell	1 -2	-67%	-$12	﹤0.01%	5647
2022 Q1	$0	Buy	+3	New	+$16	﹤0.01%	5645

Fidelity Investments's THRN Position: Q4 2023 in Review

Fidelity Investments sold out of Thorne Healthtech, Inc. Common Stock (THRN) in Q4 2023, closing a stake of 1,261 shares — an estimated $12.8K sold.

Fidelity Investments first reported a position in THRN in Q1 2022 and held it in 7 quarters. The position peaked at $12.8K in Q3 2023. 0 funds tracked by Wall St. Rank hold THRN as of Q4 2023.

Fidelity Investments reported no remaining Thorne Healthtech, Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
Fidelity Investments sold 1,261 Thorne Healthtech, Inc. Common Stock shares in Q4 2023, an estimated $12.8K.
Fidelity Investments first reported a position in Thorne Healthtech, Inc. Common Stock in Q1 2022 and held it in 7 quarters.
Fidelity Investments's Thorne Healthtech, Inc. Common Stock position peaked at $12.8K in Q3 2023.
0 funds tracked by Wall St. Rank held Thorne Healthtech, Inc. Common Stock as of Q4 2023.

Based on Fidelity Investments's 13F filing for Q4 2023, filed 13 Feb 2024.